Administrators.

Clinical trial to test a new type of therapy to treat retinitis pigmentosa.

The UK Medicines and Healthcare Regulatory Agency has accepted an application from GenSight to run the first clinical trial in the UK to test a new type of therapy with the potential to treat all forms of retinitis pigmentosa.